<!-- mobian-agent-page publisher="time" canonical="https://time.com/3716133/fda-genetic-screeing-test-bloom-syndrome/" -->

---
---

![](https://static.time.com/v3/assets/bltea6093859af6183b/blt914ca3304dd183ac/69878035cd684875eb099cc9/119021558.jpg?branch=production&width=3840&quality=75&auto=webp&crop=16:9)


# A Home Screening Test for the Bloom Syndrome Gene Has Been Approved


by 

[David Stout](https://time.com/author/david-stout/)


## David Stout


Feb 20, 2015 4:55 AM UTC

![119021558](https://static.time.com/v3/assets/bltea6093859af6183b/blt914ca3304dd183ac/69878035cd684875eb099cc9/119021558.jpg?branch=production&width=3840&quality=75&auto=webp&crop=3:2)

Gaithersburg, Maryland, USA.

Gaithersburg, Maryland, USA.Getty Images

by 

[David Stout](https://time.com/author/david-stout/)


## David Stout


Feb 20, 2015 4:55 AM UTC

The U.S. Food and Drug Administration has allowed Google-backed company 23andMe to begin marketing a home genetic test for Bloom Syndrome — an inherited condition characterized by shortness of height and increased risk of cancer.

The FDA also announced that it intends to exempt similar genetic testing devices from its premarket review protocol.

Screening tests are largely used by prospective parents who are concerned that their future children may inherent harmful genetic disorders.

“Today’s authorization … along with FDA’s intent to exempt these devices from FDA premarket review, supports innovation and will ultimately benefit consumers” [stated](http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM435003) spokesman Alberto Gutierrez.

Bloom Syndrome: FDA Approves Home Genetic Test Kit

```json
[{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/3716133/fda-genetic-screeing-test-bloom-syndrome/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/3716133/fda-genetic-screeing-test-bloom-syndrome/"},"headline":"A Home Screening Test for the Bloom Syndrome Gene Has Been Approved","datePublished":"2015-02-20T04:55:54.000Z","dateModified":"2026-02-22T04:34:13.278Z","description":"Similar genetic testing devices will also soon be exempt from the FDA's premarket review protocols","url":"https://time.com/3716133/fda-genetic-screeing-test-bloom-syndrome/","keywords":["Research","Google","FDA","health"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt914ca3304dd183ac/69878035cd684875eb099cc9/119021558.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"David Stout","jobTitle":null,"url":"https://time.com/author/david-stout/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt914ca3304dd183ac/69878035cd684875eb099cc9/119021558.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"119021558","caption":"119021558","creditText":"Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/research/","name":"Research"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/3716133/fda-genetic-screeing-test-bloom-syndrome/","name":"A Home Screening Test for the Bloom Syndrome Gene Has Been Approved"}}]}]
```

